DHR
DHR
NYSE · Life Sciences Tools & Services

Danaher Corp

$216.61
+0.86 (+0.40%)
As of Feb 12, 6:31 PM ET ·
Income Statement
FY 2026 FY 2025 FY 2025 FY 2024 FY 2023
Revenue 24.23B 24.90B 68.43B 64.73B 56.82B
Net Income 3.56B 3.30B 11.90B 10.42B 8.26B
EPS
Profit Margin 14.7% 14.0% 17.4% 16.1% 14.5%
Rev Growth -2.7% -2.7% -6.4% +18.7% +12.4%
Balance Sheet
FY 2026 FY 2025 FY 2025 FY 2024 FY 2023
Total Debt 19.86B 19.86B 63.27B 69.79B 63.61B
Total Equity 56.64B 56.64B 123.81B 119.38B 109.88B
D/E Ratio 0.35 0.35 0.51 0.58 0.58
Cash Flow
FY 2026 FY 2025 FY 2025 FY 2024 FY 2023
EBITDA 5.15B 5.02B 23.14B 20.74B 18.10B
Free Cash Flow 8.80B 7.59B 7.26B